当前位置:首页 - 行情中心 - 永顺生物(839729) - 财务分析

永顺生物

(839729)

  

流通市值:7.30亿  总市值:25.97亿
流通股本:7682.50万   总股本:2.73亿

永顺生物(839729)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.08亿元,每股收益0.03元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益67075.13万元,未分配利润13199.70万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产78901.07万元,负债11825.94万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入65,456,650.96268,985,086.87200,361,538.4119,176,173.44
营业总成本58,827,999.72233,726,259.2171,882,299.31101,264,705.6
营业利润8,718,430.1244,184,044.0732,416,644.5117,281,855.02
利润总额8,711,054.0644,507,963.7232,528,900.5917,374,117.04
净利润7,916,030.8240,143,422.4428,963,470.1915,533,898.41
其他综合收益----
综合收益总额7,916,030.8240,143,422.4428,963,470.1915,533,898.41
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计601,207,705.58564,818,676.77583,675,829.04559,004,905.13
非流动资产合计187,802,993.87195,610,979.65204,126,306.84210,343,359.1
资产总计789,010,699.45760,429,656.42787,802,135.88769,348,264.23
流动负债合计109,176,068.8390,109,813.96129,359,533.08123,639,340.13
非流动负债合计9,083,350.759,690,609.549,483,967.2910,179,860.37
负债合计118,259,419.5899,800,423.5138,843,500.37133,819,200.5
归属于母公司股东权益合计670,751,279.87660,629,232.92648,958,635.51635,529,063.73
股东权益合计670,751,279.87660,629,232.92648,958,635.51635,529,063.73
负债和股东权益合计789,010,699.45760,429,656.42787,802,135.88769,348,264.23
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计63,399,329.16274,807,406.03191,603,830.7126,232,865.92
经营活动现金流出小计46,336,875.46202,270,764.07136,288,060.2291,048,288.14
经营活动产生的现金流量净额17,062,453.772,536,641.9655,315,770.4835,184,577.78
投资活动现金流入小计120,362,370.26346,420,391.85218,736,213.26113,237,581.42
投资活动现金流出小计167,040,357.9497,050,790.38377,314,452.34249,555,462
投资活动产生的现金流量净额-46,677,987.64-150,630,398.53-158,578,239.08-136,317,880.58
筹资活动现金流入小计15,514,413.6228,893,932.227,380,732.222,646,798.01
筹资活动现金流出小计154,603.1475,456,982.249,481,106.4849,153,447.56
筹资活动产生的现金流量净额15,359,810.48-46,563,050-22,100,374.28-26,506,649.55
汇率变动对现金及现金等价物的影响133,736.22-44,808.91-249,972.0969,308.64
现金及现金等价物净增加额-14,121,987.24-124,701,615.48-125,612,814.97-127,570,643.71
期末现金及现金等价物余额22,318,586.9436,440,574.1835,529,374.6933,571,545.95
TOP↑